scholarly journals Hidradenitis suppurativa and vasculitis: A case series and literature review of a rare association

2019 ◽  
Vol 7 ◽  
pp. 2050313X1988285 ◽  
Author(s):  
Afsaneh Alavi ◽  
Eran Shavit ◽  
Jeannine Archer ◽  
Christian Pagnoux

Hidradenitis suppurativa is a chronic inflammatory skin disease with dysregulation of the immune system. Its pathophysiology is not clear, and it has been reported in association with various inflammatory disorders such as pyoderma gangrenosum, arthritis, familial Mediterranean fever and inflammatory bowel diseases. However, the co-existence of HS and vasculitis is exceptional and has not been investigated. We report on five patients with vasculitis that are followed in our centers: one with Takayasu’s arteritis, three with granulomatosis with polyangiitis and one with Behcet’s disease and compare them with those previously reported in the literature. A case series and literature review with key words of “vasculitis,” “hidradenitis suppurativa,” and “acne inversa” found only one previous report of hidradenitis suppurativa and cutaneous vasculitis and two with Behcet’s disease. Whereas the association of pyoderma gangrenosum and vasculitis is well-known, that with hidradenitis suppurativa is rarer. There may be some pathogenic continuum between hidradenitis suppurativa, pyoderma gangrenosum and vasculitis.

2011 ◽  
Vol 30 (7) ◽  
pp. 1007-1012 ◽  
Author(s):  
Afshin Borhani Haghighi ◽  
Anahid Safari ◽  
Mohammad Ali Nazarinia ◽  
Zahra Habibagahi ◽  
Saeedeh Shenavandeh

Rheumatology ◽  
2012 ◽  
Vol 51 (7) ◽  
pp. 1216-1225 ◽  
Author(s):  
N. Noel ◽  
M. Hutie ◽  
B. Wechsler ◽  
S. Vignes ◽  
D. Le Thi Huong-Boutin ◽  
...  

JRSM Open ◽  
2019 ◽  
Vol 10 (1) ◽  
pp. 205427041983484
Author(s):  
Theodoros Paschalis ◽  
Noor M Shami ◽  
Amit KJ Mandal ◽  
Constantinos G Missouris

In patients with progressive bulbar palsy without an obvious cause, there should be a high index of suspicion for the potential diagnosis of Neuro-Behçet’s Disease, even in the absence of the acute classical peripheral manifestations of Bechet’s Disease, with emphasis in prompt diagnosis using ‘The International Criteria for Behçet’s Disease’ and rapid, effective treatment in order to improve outcome.


Dermatology ◽  
2014 ◽  
Vol 228 (3) ◽  
pp. 211-214 ◽  
Author(s):  
Antonio Vitale ◽  
Donato Rigante ◽  
Francesco Caso ◽  
Maria Giuseppina Brizi ◽  
Mauro Galeazzi ◽  
...  

2015 ◽  
Vol 87 (5) ◽  
pp. 95
Author(s):  
Z. S. Alekberova ◽  
V. R. Gorodetsky ◽  
E. Т. Talybova ◽  
S. G. Radenska-lopovok ◽  
F. T. Izmailova ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Daniel Sánchez-Cano ◽  
José Luis Callejas-Rubio ◽  
Ricardo Ruiz-Villaverde ◽  
Raquel Ríos-Fernández ◽  
Norberto Ortego-Centeno

Tumoral necrosis factorαplays a central role in both the inflammatory response and that of the immune system. Thus, its blockade with the so-called anti-TNF agents (infliximab, etanercept, adalimumab, certolizumab pegol, and golimumab) has turned into the most important tool in the management of a variety of disorders, such as rheumatoid arthritis, spondyloarthropatties, inflammatory bowel disease, and psoriasis. Nonetheless, theoretically, some other autoimmune disorders may benefit from these agents. Our aim is to review these off-label uses of anti-TNF blockers in three common conditions: Behçet’s disease, sarcoidosis, and noninfectious uveitis. Due to the insufficient number of adequate clinical trials and consequently to their lower prevalence compared to other immune disorders, this review is mainly based on case reports and case series.


Sign in / Sign up

Export Citation Format

Share Document